Cybersecurity for BCIs, neuromodulation, and implantable neural devices.
Brain-computer interfaces and neuromodulation systems represent the most safety-critical class of connected medical devices. A cyber compromise can directly affect cognition, motor control, or therapeutic stimulation. We help neurotech manufacturers meet FDA's 2026 premarket cybersecurity expectations with threat models, SBOMs, and penetration testing tuned to implantable and wearable neural systems.
Neurotech and brain-computer interfaces sit at the intersection of implantable hardware, real-time signal processing, and cloud analytics. A single compromised parameter can change cognition, motor control, or therapeutic stimulation - so reviewers and IRBs treat the cybersecurity package as a patient-safety document, not an IT artifact.
Most programs we support combine an implant or wearable, a clinician programmer, a patient remote or app, and a cloud back-end for adherence and outcome data. Each interface has its own threat model, and FDA expects them documented as a system, not as isolated components.
Typical clinical uses
Key data flows & integrations
BLE and proprietary RF links to clinician programmers must be authenticated and replay-resistant - unauthenticated stimulation parameter changes can cause direct patient harm.
Implantable firmware updates require signed, attested update channels with rollback protection and out-of-band recovery paths.
Patient-facing apps frequently ship with hardcoded keys, weak TLS pinning, and over-permissioned cloud APIs.
Implantable and wearable neural systems sit on the highest-stakes safety/security boundary in MedTech - a single compromised stimulation parameter can cause direct patient harm.
OTA updates to implants are slow, power-constrained, and risk-controlled - your premarket design must minimize the need for them and document the secure update path FDA expects.
Unlike a password, neural and biometric data can't be rotated. Cloud architecture, retention, and access controls must reflect that.
When sensors, controllers, and stimulators come from different vendors, threat-model boundaries and interface contracts have to be explicit in your submission.
Implant cryptography selected today must remain defensible for 10+ years - including post-quantum migration planning.
What FDA scrutinizes
FDA expects a full SPDF: threat model, SBOM, security risk assessment tied to ISO 14971, security testing summary, and labeling - all consistent with the rest of the submission.
Reviewers want explicit analysis of how spoofed or replayed neural input is detected and how the device fails safely.
10-15 year implant lifetimes require a documented CVD process, SBOM monitoring, and a tested update mechanism.
No - cybersecurity documentation is part of your 510(k), De Novo, or PMA. We deliver an eSTAR-ready package aligned to the 2026 premarket guidance.
We use a combination of SDR-based protocol analysis, fuzzing of BLE/proprietary RF stacks, and authenticated grey-box testing of the clinician programmer.
Yes - they're modeled as part of the same system boundary. We test programmer-to-implant and remote-to-implant paths, including pairing, session management, and stimulation parameter authorization.
Closed-loop systems get a dedicated control-integrity analysis: sensing-to-stimulation latency, signal authenticity, and fail-safe behavior under spoofed or replayed neural input.
We document end-of-life cyber expectations in the SPDF and labeling - including key destruction, telemetry shutoff, and data retention boundaries on patient remotes.
Yes - long-lived implantables are exactly the use case FDA cites for needing a documented CVD process, SBOM monitoring, and a postmarket update plan.
30-minute strategy session covering implant RF, programmer, and patient app - with a fixed-fee proposal in 48 hours.
"Blue Goat Cyber's depth of expertise was impressive. We had no in-house cybersecurity experience, and their team guided us through every step of the FDA process. The penetration testing and SBOM testing were thorough and gave us complete confidence."
Cybersecurity for BCIs, neuromodulation, and implantable neural devices.
